ISHLT/Enduring Hearts Transplant Longevity Research Grant
Funds research to improve longevity and quality of life in pediatric heart transplant recipients, prioritizing clinically translatable projects in areas like rejection prevention and immunotherapy.
Funder: International Society for Heart and Lung Transplantation
Due Dates (Anticipated): September 2026 (Full application deadline, projected)
Funding Amounts: Up to $160,000 total; awarded every other year; funds must be used within 2 years of final disbursement.
Summary: Supports research to improve the longevity and quality of life for pediatric heart transplant recipients, prioritizing projects with strong clinical translation potential.
Description
This grant is a collaboration between the International Society for Heart and Lung Transplantation (ISHLT) and Enduring Hearts, designed to fund research that advances scientific understanding of factors influencing the longevity of pediatric heart transplants. The primary objective is to support projects that can be translated into clinical practice within five years, ultimately improving the quality and duration of life for pediatric heart transplant recipients and their families.
Research areas of interest include:
- Improving treatment adherence in pediatric transplant patients
- Early detection and prevention of rejection and cardiac allograft vasculopathy (CAV)
- Development of novel immunotherapies and improved immunosuppression monitoring
- Enhancing organ viability, allocation, and matching
- Establishing new nutrition and exercise guidelines to benefit long-term outcomes
Special consideration is given to projects with a clinical research component or clear potential for clinical application.
